Regeneron Pharmaceuticals (REGN)

Net Change in Cash

-$1.86B

Quarterly · Period ending: · USD

REGN logo

REGN Net Change in Cash

Latest reported-$1.86B
REGN Quarterly Net Change in Cash (-$4.20M → -$1.86B)
High-resolution chart · PNG

REGN net change in cash history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Regeneron Pharmaceuticals Net Change in Cash — Quarterly (USD)
Period endingNet Change in Cash (USD)
-40,665,000
152,642,000
-18,663,000
-32,110,000
69,457,000
-11,403,000
200,000
2,800,000
-1,100,000
2,000,000
-2,900,000
100,000
3,300,000
-9,700,000
-11,400,000
-11,200,000
23,600,000
-6,600,000
-3,000,000
-11,400,000
36,900,000
-20,800,000
26,900,000
-11,000,000
4,200,000
-11,000,000
8,500,000
-2,900,000
10,400,000
-4,800,000
-27,200,000
31,900,000
-2,300,000
-6,300,000
-2,800,000
-2,900,000
-2,800,000
-1,300,000
-8,700,000
-4,200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.